Ai Medical Technology

Dermalyser by Ai Medical Technology is a CE-marked software tool designed to assist healthcare professionals in assessing skin lesions. By using artificial intelligence to analyze dermatoscopic images captured with a smartphone, the tool delivers rapid, high-accuracy support for melanoma detection. This streamlines the clinical workflow, enabling faster diagnoses and reducing unnecessary procedures for patients.

With clinically validated performance, the tool offers sensitivity and specificity rates that rival expert human assessments, while ensuring that the final diagnostic decisions always rest with the licensed medical practitioner. The technology has demonstrated cost savings and a reduction in unneeded referrals, directly benefiting primary care settings where dermatology expertise may not always be available.

The software is intended for use exclusively by qualified healthcare professionals and is certified as a medical device under rigorous European regulations, supporting safe and responsible deployment in real-world medical environments.

Dermalyser is built for licensed medical professionals—including general practitioners, primary care physicians, and dermatologists—who regularly encounter patients with suspicious skin lesions but may lack specialist support or need quick decision assistance.

It is especially valuable in primary care and outpatient clinics, where efficient and accurate triage of potential melanomas can streamline patient flow and reduce unnecessary specialist referrals. Clinic administrators and operational leads who aim to improve diagnostic efficiency and reduce overtreatment will also find it relevant.

Hospital networks and telemedicine providers may use Dermalyser to supplement their existing diagnostic capabilities, ensuring consistent quality of care even with variable on-site expertise.